Related Experiment Video
Updated: Feb 16, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
[What's new in pediatric dermatology?]
1Centre de référence des maladies rares de la peau et des muqueuses d'origine génétique, service de dermatologie, hôpital Archet 2, CHU de Nice, France.
In 2017, pediatric dermatology saw advances in consensus recommendations for childhood psoriasis and atopic dermatitis. Research explored new treatments like JAK inhibitors for alopecia areata and sirolimus for vascular malformations.
Area of Science:
- Pediatric Dermatology
- Dermatological Research
- Clinical Advances
Background:
- 2017 highlighted significant developments in pediatric dermatology.
- Key areas included consensus recommendations and meta-analyses for common childhood skin conditions.
Purpose of the Study:
- To review the major publications and research trends in pediatric dermatology during 2017.
- To identify emerging treatments and genetic discoveries in pediatric dermatoses.
Main Methods:
- Review of consensus recommendations and meta-analyses.
- Analysis of case series and clinical articles on various dermatological conditions.
- Identification of published randomized controlled studies and genetic research.
Main Results:
- Consensus guidelines were published for childhood psoriasis, atopic dermatitis, and PHACE syndrome.
- Emerging treatments included JAK inhibitors for alopecia areata, sirolimus for vascular malformations, and MEK inhibitors for neurofibromatosis.
- Limited randomized controlled trials were noted for treatments like adalimumab and topical sirolimus.
- Clinical articles covered diverse conditions including scalp hair collar sign, prurigo, ichthyosis, atopic dermatitis, warts, and Zika virus infection.
- New genes associated with dermatoses in mosaicism were reported, opening new research avenues.
Conclusions:
- 2017 was a year of significant consensus building and exploration of novel therapeutic targets in pediatric dermatology.
- Continued research into genetic underpinnings of dermatoses and validation through randomized controlled trials are crucial for future advancements.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution

